Biologic treatment for severe asthma listed on PBS

A new pre-filled autoinjector for at-home administration of mepolizumab will be reimbursed by the PBS from 1 June Patients with severe refractory eosinophilic asthma can now choose to receive treatment with Nucala (mepolizumab) in clinic or to self-administer at home, with both options now subsidised by the government under the PBS. In late 2016, mepolizumab

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Rural pharmacies fill gap left by doctor shortages
Next Reprimands, complaints up compared to previous quarter